ARWR
Price
$16.07
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
2.22B
44 days until earnings call
LXEO
Price
$4.12
Change
-$0.06 (-1.44%)
Updated
Jun 27 closing price
Capitalization
136.75M
51 days until earnings call
Interact to see
Advertisement

ARWR vs LXEO

Header iconARWR vs LXEO Comparison
Open Charts ARWR vs LXEOBanner chart's image
Arrowhead Pharmaceuticals
Price$16.07
Change-$0.00 (-0.00%)
Volume$234
Capitalization2.22B
Lexeo Therapeutics
Price$4.12
Change-$0.06 (-1.44%)
Volume$959.83K
Capitalization136.75M
ARWR vs LXEO Comparison Chart in %
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARWR vs. LXEO commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a Hold and LXEO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (ARWR: $16.08 vs. LXEO: $4.12)
Brand notoriety: ARWR: Notable vs. LXEO: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 124% vs. LXEO: 83%
Market capitalization -- ARWR: $2.22B vs. LXEO: $136.75M
ARWR [@Biotechnology] is valued at $2.22B. LXEO’s [@Biotechnology] market capitalization is $136.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileLXEO’s FA Score has 0 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • LXEO’s FA Score: 0 green, 5 red.
According to our system of comparison, ARWR is a better buy in the long-term than LXEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 3 TA indicator(s) are bullish while LXEO’s TA Score has 6 bullish TA indicator(s).

  • ARWR’s TA Score: 3 bullish, 4 bearish.
  • LXEO’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, LXEO is a better buy in the short-term than ARWR.

Price Growth

ARWR (@Biotechnology) experienced а +4.96% price change this week, while LXEO (@Biotechnology) price change was +5.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

ARWR is expected to report earnings on Aug 11, 2025.

LXEO is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($2.22B) has a higher market cap than LXEO($137M). ARWR YTD gains are higher at: -14.468 vs. LXEO (-37.386). ARWR has higher annual earnings (EBITDA): -68.12M vs. LXEO (-107.14M). ARWR has more cash in the bank: 1.1B vs. LXEO (99.8M). LXEO has less debt than ARWR: LXEO (9.4M) vs ARWR (388M). ARWR has higher revenues than LXEO: ARWR (545M) vs LXEO (0).
ARWRLXEOARWR / LXEO
Capitalization2.22B137M1,621%
EBITDA-68.12M-107.14M64%
Gain YTD-14.468-37.38639%
P/E RatioN/AN/A-
Revenue545M0-
Total Cash1.1B99.8M1,099%
Total Debt388M9.4M4,128%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARWRLXEO
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MNHIX26.30N/A
N/A
Manning & Napier Pro-Blend Max Term I
TCMSX40.89N/A
N/A
Voya Small Cap Growth I
ICRNX10.05N/A
N/A
VY® CBRE Global Real Estate A
PRPHX65.39N/A
N/A
Permanent Portfolio Permanent C
EEMRX8.93N/A
N/A
MFS Emerging Markets Equity Research C

LXEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXEO has been loosely correlated with ARWR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if LXEO jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXEO
1D Price
Change %
LXEO100%
-1.44%
ARWR - LXEO
50%
Loosely correlated
+0.06%
COGT - LXEO
46%
Loosely correlated
-3.07%
BEAM - LXEO
43%
Loosely correlated
-2.04%
KOD - LXEO
43%
Loosely correlated
-2.38%
RGNX - LXEO
41%
Loosely correlated
-4.11%
More